Adult-onset vanishing white matter disease as differential diagnosis of primary progressive multiple sclerosis: A case report

2014 ◽  
Vol 21 (5) ◽  
pp. 666-668 ◽  
Author(s):  
Marina Herwerth ◽  
Benedikt J Schwaiger ◽  
Kornelia Kreiser ◽  
Bernhard Hemmer ◽  
Rüdiger Ilg

We report the case of a 42-year-old woman with a slowly progressive cerebellar syndrome. In contrast to a relatively mild clinical presentation, the magnetic resonance imaging (MRI) showed extensive leukencephalopathy with cystic degeneration. Initially primary progressive multiple sclerosis (PPMS) was suspected. Additional diffusion-weighted imaging revealed restricted diffusion in the white matter lesions with a reduced apparent diffusion coefficient. Genetic testing showed vanishing white matter disease (VWM) with c.260C>T EIF2B3 mutation. In conclusion, in cases with relatively mild symptoms and extensive white matter lesions, adult-onset VWM should be considered as differential diagnosis of PPMS and diffusion-weighted imaging may be helpful to identify suspected cases.

2008 ◽  
Vol 110 (10) ◽  
pp. 1068-1071 ◽  
Author(s):  
Nathalie Damon-Perriere ◽  
Patrice Menegon ◽  
Anne Olivier ◽  
Odile Boespflug-Tanguy ◽  
Florence Niel ◽  
...  

2012 ◽  
Vol 52 (8) ◽  
pp. 561-566 ◽  
Author(s):  
Shunsuke Koga ◽  
Yukari Sekiguchi ◽  
Kazuaki Kanai ◽  
Mayumi Mutoh ◽  
Satoshi Kuwabara

2021 ◽  
pp. 004-008
Author(s):  
Belarbi Soreya ◽  
Bensemmane Selma Dounia ◽  
Bouguerra Imene ◽  
Ouali Meriem ◽  
Mokrane Samira Makri

2021 ◽  
Vol 429 ◽  
pp. 118258
Author(s):  
Rim Smaoui ◽  
Khadija Sonda Moalla ◽  
Nouha Farhat ◽  
Salma Sakka ◽  
Olfa Hdiji ◽  
...  

2018 ◽  
Vol 89 (6) ◽  
pp. A38.2-A38
Author(s):  
Wilson Vallat ◽  
Timothy Kleinig

IntroductionWe present the case of a woman with an 8 year history of slowly progressive cognitive dysfunction and gait disturbance, and a diagnosis of vanishing white matter disease (VWMD).CaseThe patient struggled at work as an accountant, her hand writing became illegible, she had difficulty judging distances when driving and she had developed gait instability, slowing and falls. Her past medical history was unremarkable save for premature menopause at 35. Examination showed marked cognitive impairment ACE-R 59/100 (attention and orientation – 13/18, memory – 16/26, fluency – 1/14, language – 21/26, visuospatial – 8/16), reduced dexterity of hands, left upper limb ataxia and high- level gait dysfunction. MRI brain showed leukodystrophy with frontal predominance. Relevant investigations – white cell enzymes, very long chain fatty acids, phytanic acid, CSF were normal. In view of the clinical and radiological features genetic testing with leukodystrophy panel was performed which revealed homozygous eukaryotic translation initiation factor B3 (EIF2B3) mutation (p.Ala87Val variant). Adult onset leukodystrophies are rare genetic metabolic disorders of the glial cells. The white matter (WM) degeneration causes disruption of distributed neural networks resulting in variable constellation of cognitive dysfunction, ataxia, pyramidal and extrapyramidal signs. The clinical and radiological phenotypes overlap and there are up to 60 genes that account for adult onset leukodystrophy, which makes diagnosis challenging. Vanishing white matter disease due to EIF2B gene mutation are a group of disorders that result from mutation of any of the EIF2B subunits (1 to 5). Two thirds have associated premature ovarian failure. MRI shows confluent WM T2 high signal, subcortical U Fibre sparing, periventricular WM rarefaction and cerebral atrophy. Management is symptomatic.ConclusionAdult onset VWMD is a rare and devastating condition. When evaluating these patients targeted gene testing guided by clinical and radiological phenotype is likely to provide the highest diagnostic yield. Establishing the diagnosis is important as it has implications on future generations.


2012 ◽  
Vol 69 (6) ◽  
Author(s):  
Roberta La Piana ◽  
Adeline Vanderver ◽  
Marjo van der Knaap ◽  
Louise Roux ◽  
Donatella Tampieri ◽  
...  

2019 ◽  
Vol 116 (18) ◽  
pp. 9030-9039 ◽  
Author(s):  
Alexandra M. Nicaise ◽  
Laura J. Wagstaff ◽  
Cory M. Willis ◽  
Carolyn Paisie ◽  
Harshpreet Chandok ◽  
...  

Cellular senescence is a form of adaptive cellular physiology associated with aging. Cellular senescence causes a proinflammatory cellular phenotype that impairs tissue regeneration, has been linked to stress, and is implicated in several human neurodegenerative diseases. We had previously determined that neural progenitor cells (NPCs) derived from induced pluripotent stem cell (iPSC) lines from patients with primary progressive multiple sclerosis (PPMS) failed to promote oligodendrocyte progenitor cell (OPC) maturation, whereas NPCs from age-matched control cell lines did so efficiently. Herein, we report that expression of hallmarks of cellular senescence were identified in SOX2+ progenitor cells within white matter lesions of human progressive MS (PMS) autopsy brain tissues and iPS-derived NPCs from patients with PPMS. Expression of cellular senescence genes in PPMS NPCs was found to be reversible by treatment with rapamycin, which then enhanced PPMS NPC support for oligodendrocyte (OL) differentiation. A proteomic analysis of the PPMS NPC secretome identified high-mobility group box-1 (HMGB1), which was found to be a senescence-associated inhibitor of OL differentiation. Transcriptome analysis of OPCs revealed that senescent NPCs induced expression of epigenetic regulators mediated by extracellular HMGB1. Lastly, we determined that progenitor cells are a source of elevated HMGB1 in human white matter lesions. Based on these data, we conclude that cellular senescence contributes to altered progenitor cell functions in demyelinated lesions in MS. Moreover, these data implicate cellular aging and senescence as a process that contributes to remyelination failure in PMS, which may impact how this disease is modeled and inform development of future myelin regeneration strategies.


Sign in / Sign up

Export Citation Format

Share Document